the test is based on the marked difference in sensitivity to angiotensin ii of aldosterone-producing adenomas and hyperplastic adrenal glands and the partial angiotensin ii agonist property of saralasin in low-renin states .
C0003009
angiotensin ii
C0036193
saralasin